---
title: "BOOST Pharma ApS – CVR 41120495, financials and ownership"
description: "BOOST Pharma ApS (CVR 41120495). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Frederiksberg. 4 employees (CVR) (Jul 2026). Gross profit -7.6M DKK (2025)."
canonical_url: "https://datapublica.dk/en/companies/41120495-boost-pharma-aps"
locale: "en"
route_type: "company_overview"
robots: "index,follow"
---

# BOOST Pharma ApS

BOOST Pharma ApS \(CVR 41120495\). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Frederiksberg. 4 employees \(CVR\) \(Jul 2026\). Gross profit -7.6M DKK \(2025\).

CVR number: 41120495

## Company details

- **CVR number:** 41120495

- **Status:** Aktiv

- **Address:** Nordre Fasanvej 215, 2000, Frederiksberg

- **Legal form:** Anpartsselskab \(ApS\)

- **Founded:** Jan 20, 2020

- **Employees / FTEs:** 4 / 4

- **Production units:** 1

## Description

Selskabets hovedaktivitet består i at forske, udvikle og tilvejebringe lægemidler.

Selskabet udvikler en ny celleterapibehandling for Osteogenesis Imperfecta \(OI\), hvor det primære aktiv er BT-101.

Denne behandling er baseret på et proprietært celleprodukt, der inkluderer mesenkymale stamceller med høje knogledannende egenskaber.

I 2025 har ledelsen etableret et svensk selskab, Boost Pharma AB. I forbindelse hermed er de hidtidige aktionærers kapitalandele i Boost Pharma ApS overdraget til det svenske moderselskab og besiddes herefter indirekte gennem ejerskab i Boost Pharma AB. Boost Pharma AB ejer 100 % af kapitalandelene i Boost Pharma ApS. Den nye ejerstruktur blev gennemført i efteråret 2025.

## Activities and industry

- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

- 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

## Latest financial period

- **Reporting period:** 2025

- **Currency:** DKK

- **Gross profit:** -7,557,572

- **Operating profit:** -9,579,634

- **Profit after tax:** -9,243,488

- **Assets:** 7,206,920

- **Equity:** -11,850,535

## People

| Person | Roles | Titles |
| --- | --- | --- |
| [Hans Thalsgård Schambye](https://datapublica.dk/en/people/pid_entity_4000488020-hans-thalsg-rd-schambye) | Management | ADM. DIR. |

## Auditor

| Audit firm | Auditor | Role | From |
| --- | --- | --- | --- |
| Baker Tilly Denmark | Muqadas Rasheed | statsautoriseret revisor | Jun 24, 2026 |

## Legal owners

### Current

| Owner | Ownership | Voting rights | From |
| --- | --- | --- | --- |
| OwnerBOOST Pharma AB | Ownership100 % | Voting rights100 % | FromOct 30, 2025 |

### Previous

| Owner | Ownership | Voting rights | From | To |
| --- | --- | --- | --- | --- |
| OwnerKarolinska Development AB | Ownership10–14.99 % | Voting rights10 % | FromMar 5, 2025 | ToOct 30, 2025 |
| OwnerAnna Cecilia Götherström | Ownership20–24.99 % | Voting rights20 % | FromNov 5, 2024 | ToOct 30, 2025 |
| OwnerLilian Karin Florence Walter Jallow | Ownership20–24.99 % | Voting rights20 % | FromNov 5, 2024 | ToOct 30, 2025 |
| OwnerStiftelsen Industrifonden | Ownership10–14.99 % | Voting rights10 % | FromNov 5, 2024 | ToOct 30, 2025 |
| OwnerWestknow AB | Ownership20–24.99 % | Voting rights20 % | FromSep 2, 2021 | ToOct 30, 2025 |
| OwnerKarolinska Development AB | Ownership5–9.99 % | Voting rights5 % | FromNov 5, 2024 | ToMar 4, 2025 |
| OwnerAnna Cecilia Götherström | Ownership25–33.32 % | Voting rights25 % | FromJan 20, 2020 | ToNov 4, 2024 |
| OwnerLilian Karin Florence Walter Jallow | Ownership25–33.32 % | Voting rights25 % | FromJan 20, 2020 | ToNov 4, 2024 |
| OwnerSAUNDERS HOLDING ApS | Ownership5–9.99 % | Voting rights5 % | FromMar 3, 2021 | ToMay 23, 2024 |
| OwnerLars Magnus Reinhold Westgren | Ownership25–33.32 % | Voting rights25 % | FromJan 20, 2020 | ToSep 2, 2021 |

## Ultimate owners
[View ownership diagram](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/portfolio)
| Name | Ownership through | Calculated ownership |
| --- | --- | --- |
| BOOST Pharma AB | Direct | 100 % |

## Company pages

- [Overview](https://datapublica.dk/en/companies/41120495-boost-pharma-aps)

- [Financial report](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/financials)

- [Risk](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/risk)

- [Timeline](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/timeline)

- [Ownership and relations](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/portfolio)

- [Production units](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/production-units)

- [Gazelle](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/gazelle)

- [Investments](https://datapublica.dk/en/companies/41120495-boost-pharma-aps/investments)

## Official sources

- [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/41120495)